Effect of Moringa Oleifera Leaf Nanoparticles on IL-10 in Vivo Model of Oral Cavity Malignancy
DOI:
10.29303/jbt.v26i1.11489Published:
2026-03-31Downloads
Abstract
Interleukin-10 (IL-10) which is secreted by Th 2 cells. Interleukin- 10 is an anti-inflammatory cytokine that plays an important role in the regulation of the host immune response by inhibiting the release of pro-inflammatory mediators. Moringa leaf nanoparticles (Moringa oleifera) are products that contain various bioactive mediators that can play a role in inflammation. The aim of this study was to determine the effect of administering Moringa leaf extract nanoparticles on IL-10 levels in oral cavity cells undergoing malignant transformation. Eighteen male Wistar rats (R. novergicus) were used as animal models that underwent benzo(a)pyrene induced malignant transformation in the oral cavity. Moringa leaf extract nanoparticles with concentrations of 0.250 mg/mL, and 0.500 mg/ were given to the treatment group for 14 days. The results of IL-10 levels were evaluated using the ELISA method. Data analysis using the Kruskall-Wallis test was carried out to analyze differences between groups. Aplication Moringa oleifera leaf nanoparticles with concentrations of 0.250 mg/mL, and 0.500 mg/mL were able to reduce levels of IL-10 in oral cells undergoing malignant transformation. The results of this study showed that the p-value = 0.726 (> 0.05) which means that there was no effect of the application of moringa leaf extract nanoparticles in a mouse model with malignant transformation of oral cells on reducing IL-10 levels.
Keywords:
Malignant transformation, Moringa oleifera, Nanoparticles, Oral Cancer, Inflammation, IL-10.References
Budhy, T. I., Adam, D., Azis, Z. M. R., Syahputri, V., Yuliani, M. G. A., Suwarto, M. F. S., & Setiawan, F. (2023). The Potential of Moringa Leaf Nanoparticles (Moringa oleifera) on the Expression of TNFα, IL10, and HSP 27 in Oral Cavity Cancer. Journal of Multidisciplinary Applied Natural Science, 4(1), 120–129. Advance online publication. DOI: https://doi.org/10.47352/jmans.2774-3047.198
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023). The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Journal Frontiers in Immunology, 14, 1161067. Advance online publication. DOI: https://doi.org/10.3389/fimmu.2023.1161067
Celakovská J, Čermáková E, Boudková P, Krejsek J. Evaluation of the levels of interleukins IL-4, IL-13, IL-5, IL-10 and IL-33 in atopic dermatitis patients with and without dupilumab therapy. Front Immunol. 2025 Jul 23;16:1604883. doi: 10.3389/fimmu.2025.1604883. PMID: 40771803; PMCID: PMC12325203.
Chiș, A., Noubissi, P. A., Pop, O.-L., Mureșan, C. I., Fokam Tagne, M. A., Kamgang, R., Fodor, A., Sitar-Tăut, A.-V., Cozma, A., Orășan, O. H., Hegheș, S. C., Vulturar, R., & Suharoschi, R. (2023). Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties. Journal Plants, 13(1), 20. Advance online publication. DOI: https://doi.org/10.3390/plants13010020
Chiswick, E. L., Duffy, E., Japp, B., & Remick, D. (2012). Detection and Quantification of Cytokines and Other Biomarkers. Dalam R. B. Ashman (Ed.), Leucocytes. Journal Humana Press 844, 15–30. Advance online publication. DOI: https://doi.org/10.1007/978-1-61779-527-5_2
Jayachandran, S., Preethi, M., & Nagarajan, N. (2024). Salivary interleukin-10 and interleukin-17 – Potential biomarkers for assessing oral cancer and oral potentially malignant disorders. Indian Journal of Cancer. https://doi.org/10.4103/ijc.ijc_610_21
Kou, X., Li, B., Olayanju, J., Drake, J., & Chen, N. (2018). Nutraceutical or Pharmacological Potential of Moringa oleifera Lam. Journal Nutrients, 10(3), 343. Advance online publication. DOI: https://doi.org/10.3390/nu10030343
Li, C., Dong, X., & Li, B. (2024). Tumor microenvironment in oral squamous cell carcinoma. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1485174
Nakase, H., & Shimomori, Y. (2025). Association of Chronic Inflammation-Associated Cancer With Cytokines. Journal Cureus. 1(10). Advance online publication. DOI: https://doi.org/10.7759/cureus.92239
Nokovitch, L., Maquet, C., Crampon, F., Taihi, I., Roussel, L.-M., Obongo, R., Virard, F., Fervers, B., & Deneuve, S. (2023). Oral Cavity Squamous Cell Carcinoma Risk Factors: State of the Art. Journal of Clinical Medicine, 12(9), 3264. Advance online publication. DOI: https://doi.org/10.3390/jcm12093264
Perumalsamy, H., Balusamy, S. R., Sukweenadhi, J., Nag, S., MubarakAli, D., El-Agamy Farh, M., Vijay, H., & Rahimi, S. (2024). A comprehensive review on Moringa oleifera nanoparticles: Importance of polyphenols in nanoparticle synthesis, nanoparticle efficacy and their applications. Journal of Nanobiotechnology, 22(1), 71. Advance online publication. DOI: https://doi.org/10.1186/s12951-024-02332-8
Ramamurthy, S., Varghese, S., Sudarsan, S., Muruganandhan, J., Mushtaq, S., Patil, P. B., Raj, A. T., Zanza, A., Testarelli, L., & Patil, S. (2021). Moringa oleifera: Antioxidant, Anticancer, Anti-inflammatory, and Related Properties of Extracts in Cell Lines: A Review of Medicinal Effects, Phytochemistry, and Applications. 22(12), 1483–1492. Advance online publication. DOI: https://pubmed.ncbi.nlm.nih.gov/35656691/
Ramdhiani, N. D., & Amin, S. (2025). Flavonoid Sebagai Agen Antikanker: Tinjauan Kimia Medisinal Dan Aktivitas Biologis. Journal An-Najat, 3(4), 12–22. Advance online publication. DOI: https://doi.org/10.59841/an-najat.v3i4.3411
Rosyidah, N. E., & Budhy, T. I. (2022). The Role Of Moringa Leaf Extract (Moringa Oleifera) On Interleukin-10 Levels In Chronic Inflammation Of The Dermis Of White Wistar Rats (Rattus Norvegicus). Jurnal Biosains Pascasarjana, 24(1), 23–28. Advance online publication. DOI: https://doi.org/10.20473/jbp.v24i1.2022.23-28
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. Advance online publication. DOI:https://doi.org/10.3322/caac.21660
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023). Oral squamous cell carcinomas: State of the field and emerging directions. International Journal of Oral Science, 15(1), 44. Advance online publication. DOI: https://doi.org/10.1038/s41368-023-00249-w
Warnakulasuriya, S., Kujan, O., Aguirre‐Urizar, J. M., Bagan, J. V., González‐Moles, M. Á., Kerr, A. R., Lodi, G., Mello, F. W., Monteiro, L., Ogden, G. R., Sloan, P., & Johnson, N. W. (2021). Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Diseases, 27(8), 1862–1880. Advance online publication. DOI: https://doi.org/10.1111/odi.13704
License
Copyright (c) 2026 Mariana Asmaningdiah, Alfia Andriyani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
